Trafficking of receptor tyrosine kinases to the nucleus

Experimental Cell Research

Volumn 315, Issue 9, 2009, Pages 1556-1566

  Carpenter, Graham ^a   Liao, Hong Jun ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

EGF receptor; ErbB receptors; Nucleus; Receptor tyrosine kinase; Trafficking

Indexed keywords

EPHRIN RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 4; GAMMA SECRETASE; INSULIN RECEPTOR; PROTEIN TYROSINE KINASE; SOMATOMEDIN C; TIE 1 RECEPTOR; TRANSLOCON; VASCULOTROPIN RECEPTOR 1;

CELL MIGRATION; CELL NUCLEUS; CELL SELECTION; CELL SURFACE; CYTOPLASM; HUMAN; MITOCHONDRION; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN DEGRADATION; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 67349270856     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2008.09.027     Document Type: Review

References (155)

1. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 103 (2000) 211-225
2. Miaczynska M., Pelkmans L., and Zerial M. Not just a sink: endosomes in control of signal transduction. Curr. Opin. Cell. Biol. 16 (2004) 400-406
3. Sorkin A., and Von Zastrow M. Signal transduction and endocytosis: close encounters of many kinds. Nat. Rev. Mol. Cell Biol. 3 (2002) 600-614
4. Bray S.J. Notch signalling: a simple pathway becomes complex. Nat. Rev. Mol. Cell Biol. 7 (2006) 678-689
5. Kopan R., and Ilagan M.X. γ-Secretase: proteasome of the membrane?. Nat. Rev. Mol. Cell Biol. 5 (2004) 499-504
6. Small D.H. Is γ-secretase a multienzyme complex for membrane protein degradation? Models and speculations. Peptides 23 (2002) 1317-1321
7. Vecchi M., Baulida J., and Carpenter G. Selective cleavage of the heregulin receptor ErbB-4 by protein kinase C activation. J. Biol. Chem. 271 (1996) 18989-18995
8. Zhou W., and Carpenter G. Heregulin-dependent trafficking and cleavage of ErbB-4. J. Biol. Chem. 275 (2000) 34737-34743
9. Cheng Q.C., Tikhomirov O., Zhou W., and Carpenter G. Ectodomain cleavage of ErbB-4: characterization of the cleavage site and m80 fragment. J. Biol. Chem. 278 (2003) 38421-38427
10. Rio C., Buxbaum J.D., Peschon J.J., and Corfas G. Tumor necrosis factor-α-converting enzyme is required for cleavage of erbB4/HER4. J. Biol. Chem. 275 (2000) 10379-10387
11. Migaki G.I., Kahn J., and Kishimoto T.K. Mutational analysis of the membrane-proximal cleavage site of l-selectin: relaxed sequence specificity surrounding the cleavage site. J. Exp. Med. 182 (1995) 549-557
12. Elenius K., Corfas G., Paul S., Choi C.J., Rio C., Plowman G.D., and Klagsbrun M. A novel juxtamembrane domain isoform of HER4/ErbB4. Isoform-specific tissue distribution and differential processing in response to phorbol ester. J. Biol. Chem. 272 (1997) 26761-26768
13. Struhl G., and Adachi A. Requirements for presenilin-dependent cleavage of notch and other transmembrane proteins. Mol. Cell 6 (2000) 625-636
14. Ni C.Y., Murphy M.P., Golde T.E., and Carpenter G. γ-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science 294 (2001) 2179-2181
15. Selkoe D.J., and Wolfe M.S. Presenilin: running with scissors in the membrane. Cell 131 (2007) 215-221
16. Shah S., Lee S.F., Tabuchi K., Hao Y.H., Yu C., LaPlant Q., Ball H., Dann III C.E., Sudhof T., and Yu G. Nicastrin functions as a γ-secretase-substrate receptor. Cell 122 (2005) 435-447
17. Naresh A., Long W., Vidal G.A., Wimley W.C., Marrero L., Sartor C.I., Tovey S., Cooke T.G., Bartlett J.M., and Jones F.E. The ERBB4/HER4 intracellular domain 4ICD is a BH3-only protein promoting apoptosis of breast cancer cells. Cancer Res. 66 (2006) 6412-6420
18. Ni C.Y., Yuan H., and Carpenter G. Role of the ErbB-4 carboxyl terminus in γ-secretase cleavage. J. Biol. Chem. 278 (2003) 4561-4565
19. Varshavsky A. The N-end rule pathway of protein degradation. Genes Cells 2 (1997) 13-28
20. Tagami S., et al. Regulation of Notch signaling by dynamic changes in the precision of S3 cleavage of Notch-1. Mol. Cell. Biol. 28 (2008) 165-176
21. Muraoka-Cook R.S., Sandahl M., Husted C., Hunter D., Miraglia L., Feng S.M., Elenius K., and Earp III H.S. The intracellular domain of ErbB4 induces differentiation of mammary epithelial cells. Mol. Biol. Cell. 17 (2006) 4118-4129
22. Vidal G.A., Naresh A., Marrero L., and Jones F.E. Presenilin-dependent γ-secretase processing regulates multiple ERBB4/HER4 activities. J. Biol. Chem. 280 (2005) 19777-19783
23. Sardi S.P., Murtie J., Koirala S., Patten B.A., and Corfas G. Presenilin-dependent ErbB4 nuclear signaling regulates the timing of astrogenesis in the developing brain. Cell 127 (2006) 185-197
24. Williams C.C., Allison J.G., Vidal G.A., Burow M.E., Beckman B.S., Marrero L., and Jones F.E. The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone. J. Cell Biol. 167 (2004) 469-478
25. Jones F.E. HER4 intracellular domain (4ICD) activity in the developing mammary gland and breast cancer. J. Mammary Gland Biol. Neoplasia. 13 (2008) 247-258
26. Lai C., and Feng L. Implication of γ-secretase in neuregulin-induced maturation of oligodendrocytes. Biochem. Biophys. Res. Commun. 314 (2004) 535-542
27. Linggi B., and Carpenter G. ErbB-4 s80 intracellular domain abrogates ETO2-dependent transcriptional repression. J. Biol. Chem. 281 (2006) 25373-25380
28. Komuro A., Nagai M., Navin N.E., and Sudol M. WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus. J. Biol. Chem. 278 (2003) 33334-33341
29. Omerovic J., Puggioni E.M., Napoletano S., Visco V., Fraioli R., Frati L., Gulino A., and Alimandi M. Ligand-regulated association of ErbB-4 to the transcriptional co-activator YAP65 controls transcription at the nuclear level. Exp. Cell Res. 294 (2004) 469-479
30. Aqeilan R.I., Donati V., Palamarchuk A., Trapasso F., Kaou M., Pekarsky Y., Sudol M., and Croce C.M. WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function. Cancer Res. 65 (2005) 6764-6772
31. Zhu Y., Sullivan L.L., Nair S.S., Williams C.C., Pandey A.K., Marrero L., Vadlamudi R.K., and Jones F.E. Coregulation of estrogen receptor by ERBB4/HER4 establishes a growth-promoting autocrine signal in breast tumor cells. Cancer Res. 66 (2006) 7991-7998
32. Arasada R.R., and Carpenter G. Secretase-dependent tyrosine phosphorylation of Mdm2 by the ErbB-4 intracellular domain fragment. J. Biol. Chem. 280 (2005) 30783-30787
33. Omerovic J., et al. The E3 ligase Aip4/Itch ubiquitinates and targets ErbB-4 for degradation. FASEB J. 21 (2007) 2849-2862
34. Linggi B., Cheng Q.C., Rao A.R., and Carpenter G. The ErbB-4 s80 intracellular domain is a constitutively active tyrosine kinase. Oncogene 25 (2006) 160-163
35. Litterst C., Georgakopoulos A., Shioi J., Ghersi E., Wisniewski T., Wang R., Ludwig A., and Robakis N.K. Ligand binding and calcium influx induce distinct ectodomain/γ-secretase-processing pathways of EphB2 receptor. J. Biol. Chem. 282 (2007) 16155-16163
36. Glenn G., and van der Geer P. CSF-1 and TPA stimulate independent pathways leading to lysosomal degradation or regulated intramembrane proteolysis of the CSF-1 receptor. FEBS Lett. 581 (2007) 5377-5381
37. Glenn G., and van der Geer P. Toll-like receptors stimulate regulated intramembrane proteolysis of the CSF-1 receptor through Erk activation. FEBS Lett. 582 (2008) 911-915
38. Wilhelmsen K., and van der Geer P. Phorbol 12-myristate 13-acetate-induced release of the colony-stimulating factor 1 receptor cytoplasmic domain into the cytosol involves two separate cleavage events. Mol. Cell. Biol. 24 (2004) 454-464
39. Cai J., Jiang W.G., Grant M.B., and Boulton M. Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1. J. Biol. Chem. 281 (2006) 3604-3613
40. Marron M.B., Singh H., Tahir T.A., Kavumkal J., Kim H.Z., Koh G.Y., and Brindle N.P. Regulated proteolytic processing of Tie1 modulates ligand responsiveness of the receptor-tyrosine kinase Tie2. J. Biol. Chem. 282 (2007) 30509-30517
41. Kasuga K., Kaneko H., Nishizawa M., Onodera O., and Ikeuchi T. Generation of intracellular domain of insulin receptor tyrosine kinase by γ-secretase. Biochem. Biophys. Res. Commun. 360 (2007) 90-96
42. McElroy B., Powell J.C., and McCarthy J.V. The insulin-like growth factor 1 (IGF-1) receptor is a substrate for γ-secretase-mediated intramembrane proteolysis. Biochem. Biophys. Res. Commun. 358 (2007) 1136-1141
43. Benoit V., Chariot A., Delacroix L., Deregowski V., Jacobs N., Merville M.P., and Bours V. Caspase-8-dependent HER-2 cleavage in response to tumor necrosis factor α stimulation is counteracted by nuclear factor κB through c-FLIP-L expression. Cancer Res. 64 (2004) 2684-2691
44. Strohecker A.M., Yehiely F., Chen F., and Cryns V.L. Caspase cleavage of HER-2 releases a bad-like cell death effector. J. Biol. Chem. 283 (2008) 18269-18282
45. Tikhomirov O., and Carpenter G. Caspase-dependent cleavage of ErbB-2 by geldanamycin and staurosporin. J. Biol. Chem. 276 (2001) 33675-33680
46. Bordeaux M.C., Forcet C., Granger L., Corset V., Bidaud C., Billaud M., Bredesen D.E., Edery P., and Mehlen P. The RET proto-oncogene induces apoptosis: a novel mechanism for Hirschsprung disease. EMBO J. 19 (2000) 4056-4063
47. Mourali J., et al. Anaplastic lymphoma kinase is a dependence receptor whose proapoptotic functions are activated by caspase cleavage. Mol. Cell. Biol. 26 (2006) 6209-6222
48. Tauszig-Delamasure S., Yu L.Y., Cabrera J.R., Bouzas-Rodriguez J., Mermet-Bouvier C., Guix C., Bordeaux M.C., Arumae U., and Mehlen P. The TrkC receptor induces apoptosis when the dependence receptor notion meets the neurotrophin paradigm. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 13361-13366
49. Foveau B., Leroy C., Ancot F., Deheuninck J., Ji Z., Fafeur V., and Tulasne D. Amplification of apoptosis through sequential caspase cleavage of the MET tyrosine kinase receptor. Cell Death Differ. 14 (2007) 752-764
50. Pozner-Moulis S., Pappas D.J., and Rimm D.L. Met, the hepatocyte growth factor receptor, localizes to the nucleus in cells at low density. Cancer Res. 66 (2006) 7976-7982
51. Tulasne D., et al. Proapoptotic function of the MET tyrosine kinase receptor through caspase cleavage. Mol. Cell. Biol. 24 (2004) 10328-10339
52. Lin S.Y., Makino K., Xia W., Matin A., Wen Y., Kwong K.Y., Bourguignon L., and Hung M.C. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat. Cell Biol. 3 (2001) 802-808
53. Hanada N., Lo H.W., Day C.P., Pan Y., Nakajima Y., and Hung M.C. Co-regulation of B-Myb expression by E2F1 and EGF receptor. Mol. Carcinog. 45 (2006) 10-17
54. Lo H.W., Hsu S.C., Ali-Seyed M., Gunduz M., Xia W., Wei Y., Bartholomeusz G., Shih J.Y., and Hung M.C. Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway. Cancer Cell 7 (2005) 575-589
55. Tao Y., et al. Nuclear accumulation of epidermal growth factor receptor and acceleration of G1/S stage by Epstein-Barr-encoded oncoprotein latent membrane protein 1. Exp. Cell Res. 303 (2005) 240-251
56. Lo H.W., Ali-Seyed M., Wu Y., Bartholomeusz G., Hsu S.C., and Hung M.C. Nuclear-cytoplasmic transport of EGFR involves receptor endocytosis, importin β1 and CRM1. J. Cell Biochem. 98 (2006) 1570-1583
57. Hsu S.C., and Hung M.C. Characterization of a novel tripartite nuclear localization sequence in the EGFR family. J. Biol. Chem. 282 (2007) 10432-10440
58. Wang S.C., et al. Tyrosine phosphorylation controls PCNA function through protein stability. Nat. Cell Biol. 8 (2006) 1359-1368
59. Carpenter G. Nuclear localization and possible functions of receptor tyrosine kinases. Curr. Opin. Cell Biol. 15 (2003) 143-148
60. Liao H.J., and Carpenter G. Role of the Sec61 translocon in EGF receptor trafficking to the nucleus and gene expression. Mol. Biol. Cell 18 (2007) 1064-1072
61. Johnson H.M., Subramaniam P.S., Olsnes S., and Jans D.A. Trafficking and signaling pathways of nuclear localizing protein ligands and their receptors. Bioessays 26 (2004) 993-1004
62. Olsnes S., Klingenberg O., and Wiedlocha A. Transport of exogenous growth factors and cytokines to the cytosol and to the nucleus. Physiol. Rev. 83 (2003) 163-182
63. Planque N. Nuclear trafficking of secreted factors and cell-surface receptors: new pathways to regulate cell proliferation and differentiation, and involvement in cancers. Cell Commun. Signal. 4 (2006) 7
64. Fluhrer R., et al. A γ-secretase-like intramembrane cleavage of TNFα by the GxGD aspartyl protease SPPL2b. Nat. Cell Biol. 8 (2006) 894-896
65. Friedmann E., Hauben E., Maylandt K., Schleeger S., Vreugde S., Lichtenthaler S.F., Kuhn P.H., Stauffer D., Rovelli G., and Martoglio B. SPPL2a and SPPL2b promote intramembrane proteolysis of TNFα in activated dendritic cells to trigger IL-12 production. Nat. Cell Biol. 8 (2006) 843-848
66. Bao J., Lin H., Ouyang Y., Lei D., Osman A., Kim T.W., Mei L., Dai P., Ohlemiller K.K., and Ambron R.T. Activity-dependent transcription regulation of PSD-95 by neuregulin-1 and Eos. Nat. Neurosci. 7 (2004) 1250-1258
67. Bao J., Wolpowitz D., Role L.W., and Talmage D.A. Back signaling by the Nrg-1 intracellular domain. J. Cell Biol. 161 (2003) 1133-1141
68. Ikeuchi T., and Sisodia S.S. The Notch ligands, Delta1 and Jagged2, are substrates for presenilin-dependent "γ-secretase" cleavage. J. Biol. Chem. 278 (2003) 7751-7754
69. LaVoie M.J., and Selkoe D.J. The Notch ligands, Jagged and Delta, are sequentially processed by α-secretase and presenilin/γ-secretase and release signaling fragments. J. Biol. Chem. 278 (2003) 34427-34437
70. Six E., Ndiaye D., Laabi Y., Brou C., Gupta-Rossi N., Israel A., and Logeat F. The Notch ligand Delta1 is sequentially cleaved by an ADAM protease and γ-secretase. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 7638-7643
71. Georgakopoulos A., Litterst C., Ghersi E., Baki L., Xu C., Serban G., and Robakis N.K. Metalloproteinase/Presenilin1 processing of ephrinB regulates EphB-induced Src phosphorylation and signaling. EMBO J. 25 (2006) 1242-1252
72. Tomita T., Tanaka S., Morohashi Y., and Iwatsubo T. Presenilin-dependent intramembrane cleavage of ephrin-B1. Mol. Neurodegener. 1 (2006) 2
73. Anders L., Mertins P., Lammich S., Murgia M., Hartmann D., Saftig P., Haass C., and Ullrich A. Furin-, ADAM 10-, and γ-secretase-mediated cleavage of a receptor tyrosine phosphatase and regulation of β-catenin's transcriptional activity. Mol. Cell. Biol. 26 (2006) 3917-3934
74. Haapasalo A., Kim D.Y., Carey B.W., Turunen M.K., Pettingell W.H., and Kovacs D.M. Presenilin/γ-secretase-mediated cleavage regulates association of leukocyte-common antigen-related (LAR) receptor tyrosine phosphatase with β-catenin. J. Biol. Chem. 282 (2007) 9063-9072
75. Frade J.M. Nuclear translocation of the p75 neurotrophin receptor cytoplasmic domain in response to neurotrophin binding. J. Neurosci. 25 (2005) 1407-1411
76. Jung K.M., et al. Regulated intramembrane proteolysis of the p75 neurotrophin receptor modulates its association with the TrkA receptor. J. Biol. Chem. 278 (2003) 42161-42169
77. Kanning K.C., Hudson M., Amieux P.S., Wiley J.C., Bothwell M., and Schecterson L.C. Proteolytic processing of the p75 neurotrophin receptor and two homologs generates C-terminal fragments with signaling capability. J. Neurosci. 23 (2003) 5425-5436
78. Kenchappa R.S., Zampieri N., Chao M.V., Barker P.A., Teng H.K., Hempstead B.L., and Carter B.D. Ligand-dependent cleavage of the P75 neurotrophin receptor is necessary for NRIF nuclear translocation and apoptosis in sympathetic neurons. Neuron 50 (2006) 219-232
79. Underwood C.K., Reid K., May L.M., Bartlett P.F., and Coulson E.J. Palmitoylation of the C-terminal fragment of p75(NTR) regulates death signaling and is required for subsequent cleavage by γ-secretase. Mol. Cell Neurosci. 37 (2008) 346-358
80. Urra S., et al. TrkA receptor activation by nerve growth factor induces shedding of the p75 neurotrophin receptor followed by endosomal γ-mediated release of the p75 intracellular domain. J. Biol. Chem. 282 (2007) 7606-7615
81. Zampieri N., Xu C.F., Neubert T.A., and Chao M.V. Cleavage of p75 neurotrophin receptor by α-secretase and γ-secretase requires specific receptor domains. J. Biol. Chem. 280 (2005) 14563-14571
82. Kuhn P.H., Marjaux E., Imhof A., De Strooper B., Haass C., and Lichtenthaler S.F. Regulated intramembrane proteolysis of the interleukin-1 receptor II by α-, β-, and γ-secretase. J. Biol. Chem. 282 (2007) 11982-11995
83. Cowan J.W., Wang X., Guan R., He K., Jiang J., Baumann G., Black R.A., Wolfe M.S., and Frank S.J. Growth hormone receptor is a target for presenilin-dependent γ-secretase cleavage. J. Biol. Chem. 280 (2005) 19331-19342
84. Meyer E.L., Strutz N., Gahring L.C., and Rogers S.W. Glutamate receptor subunit 3 is modified by site-specific limited proteolysis including cleavage by γ-secretase. J. Biol. Chem. 278 (2003) 23786-23796
85. Kinoshita A., Shah T., Tangredi M.M., Strickland D.K., and Hyman B.T. The intracellular domain of the low density lipoprotein receptor-related protein modulates transactivation mediated by amyloid precursor protein and Fe65. J. Biol. Chem. 278 (2003) 41182-41188
86. Liu C.X., Ranganathan S., Robinson S., and Strickland D.K. γ-Secretase-mediated release of the low density lipoprotein receptor-related protein 1B intracellular domain suppresses anchorage-independent growth of neuroglioma cells. J. Biol. Chem. 282 (2007) 7504-7511
87. May P., Bock H.H., Nimpf J., and Herz J. Differential glycosylation regulates processing of lipoprotein receptors by γ-secretase. J. Biol. Chem. 278 (2003) 37386-37392
88. May P., Reddy Y.K., and Herz J. Proteolytic processing of low density lipoprotein receptor-related protein mediates regulated release of its intracellular domain. J. Biol. Chem. 277 (2002) 18736-18743
89. Mi K., and Johnson G.V. Regulated proteolytic processing of LRP6 results in release of its intracellular domain. J. Neurochem. 101 (2007) 517-529
90. Zou Z., Chung B., Nguyen T., Mentone S., Thomson B., and Biemesderfer D. Linking receptor-mediated endocytosis and cell signaling: evidence for regulated intramembrane proteolysis of megalin in proximal tubule. J. Biol. Chem. 279 (2004) 34302-34310
91. Schulte A., et al. Sequential processing of the transmembrane chemokines CX3CL1 and CXCL16 by α- and γ-secretases. Biochem. Biophys. Res. Commun. 358 (2007) 233-240
92. El Fiky A., Arch A.E., and Krolewski J.J. Intracellular domain of the IFNaR2 interferon receptor subunit mediates transcription via Stat2. J. Cell Physiol. 204 (2005) 567-573
93. El Fiky A., Pioli P., Azam A., Yoo K., Nastiuk K.L., and Krolewski J.J. Nuclear transit of the intracellular domain of the interferon receptor subunit IFNaR2 requires Stat2 and Irf9. Cell Signal. 20 (2008) 1400-1408
94. Saleh A.Z., Fang A.T., Arch A.E., Neupane D., El Fiky A., and Krolewski J.J. Regulated proteolysis of the IFNaR2 subunit of the interferon-α receptor. Oncogene 23 (2004) 7076-7086
95. Kim D.Y., et al. BACE1 regulates voltage-gated sodium channels and neuronal activity. Nat. Cell Biol. 9 (2007) 755-764
96. Kim D.Y., Ingano L.A., Carey B.W., Pettingell W.H., and Kovacs D.M. Presenilin/γ-secretase-mediated cleavage of the voltage-gated sodium channel β 2-subunit regulates cell adhesion and migration. J. Biol. Chem. 280 (2005) 23251-23261
97. Wong H.K., Sakurai T., Oyama F., Kaneko K., Wada K., Miyazaki H., Kurosawa M., De Strooper B., Saftig P., and Nukina N. β Subunits of voltage-gated sodium channels are novel substrates of β-site amyloid precursor protein-cleaving enzyme (BACE1) and γ-secretase. J. Biol. Chem. 280 (2005) 23009-23017
98. Lammich S., Okochi M., Takeda M., Kaether C., Capell A., Zimmer A.K., Edbauer D., Walter J., Steiner H., and Haass C. Presenilin-dependent intramembrane proteolysis of CD44 leads to the liberation of its intracellular domain and the secretion of an A β-like peptide. J. Biol. Chem. 277 (2002) 44754-44759
99. Murakami D., Okamoto I., Nagano O., Kawano Y., Tomita T., Iwatsubo T., De Strooper B., Yumoto E., and Saya H. Presenilin-dependent γ-secretase activity mediates the intramembranous cleavage of CD44. Oncogene 22 (2003) 1511-1516
100. Okamoto I., Kawano Y., Murakami D., Sasayama T., Araki N., Miki T., Wong A.J., and Saya H. Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway. J. Cell Biol. 155 (2001) 755-762
101. Pelletier L., Guillaumot P., Freche B., Luquain C., Christiansen D., Brugiere S., Garin J., and Manie S.N. γ-secretase-dependent proteolysis of CD44 promotes neoplastic transformation of rat fibroblastic cells. Cancer Res. 66 (2006) 3681-3687
102. Bonn S., Seeburg P.H., and Schwarz M.K. Combinatorial expression of α- and γ-protocadherins alters their presenilin-dependent processing. Mol. Cell. Biol. 27 (2007) 4121-4132
103. Ferber E.C., Kajita M., Wadlow A., Tobiansky L., Niessen C., Ariga H., Daniel J., and Fujita Y. A role for the cleaved cytoplasmic domain of E-cadherin in the nucleus. J. Biol. Chem. 283 (2008) 12691-12700
104. Haas I.G., Frank M., Veron N., and Kemler R. Presenilin-dependent processing and nuclear function of γ-protocadherins. J. Biol. Chem. 280 (2005) 9313-9319
105. Hambsch B., Grinevich V., Seeburg P.H., and Schwarz M.K. γ-Protocadherins, presenilin-mediated release of C-terminal fragment promotes locus expression. J. Biol. Chem. 280 (2005) 15888-15897
106. Marambaud P., et al. A presenilin-1/γ-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. EMBO J. 21 (2002) 1948-1956
107. Marambaud P., Wen P.H., Dutt A., Shioi J., Takashima A., Siman R., and Robakis N.K. A CBP binding transcriptional repressor produced by the PS1/epsilon-cleavage of N-cadherin is inhibited by PS1 FAD mutations. Cell 114 (2003) 635-645
108. Wu S., Rhee K.J., Zhang M., Franco A., and Sears C.L. Bacteroides fragilis toxin stimulates intestinal epithelial cell shedding and γ-secretase-dependent E-cadherin cleavage. J. Cell Sci. 120 (2007) 1944-1952
109. Taniguchi Y., Kim S.H., and Sisodia S.S. Presenilin-dependent "γ-secretase" processing of deleted in colorectal cancer (DCC). J. Biol. Chem. 278 (2003) 30425-30428
110. Schulz J.G., Annaert W., Vandekerckhove J., Zimmermann P., De Strooper B., and David G. Syndecan 3 intramembrane proteolysis is presenilin/γ-secretase-dependent and modulates cytosolic signaling. J. Biol. Chem. 278 (2003) 48651-48657
111. Maretzky T., Schulte M., Ludwig A., Rose-John S., Blobel C., Hartmann D., Altevogt P., Saftig P., and Reiss K. L1 is sequentially processed by two differently activated metalloproteases and presenilin/γ-secretase and regulates neural cell adhesion, cell migration, and neurite outgrowth. Mol. Cell. Biol. 25 (2005) 9040-9053
112. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 430 (2004) 631-639
113. Ali N., and Knauper V. Phorbol ester-induced shedding of the prostate cancer marker transmembrane protein with epidermal growth factor and two follistatin motifs 2 is mediated by the disintegrin and metalloproteinase-17. J. Biol. Chem. 282 (2007) 37378-37388
114. Andersson C.X., Fernandez-Rodriguez J., Laos S., Baeckstrom D., Haass C., and Hansson G.C. Shedding and γ-secretase-mediated intramembrane proteolysis of the mucin-type molecule CD43. Biochem. J. 387 (2005) 377-384
115. Andersson C.X., Fernandez-Rodriguez J., Laos S., Sikut R., Sikut A., Baeckstrom D., and Hansson G.C. CD43 has a functional NLS, interacts with β-catenin, and affects gene expression. Biochem. Biophys. Res. Commun. 316 (2004) 12-17
116. Becker-Herman S., Arie G., Medvedovsky H., Kerem A., and Shachar I. CD74 is a member of the regulated intramembrane proteolysis-processed protein family. Mol. Biol. Cell. 16 (2005) 5061-5069
117. Bohm C., Seibel N.M., Henkel B., Steiner H., Haass C., and Hampe W. SorLA signaling by regulated intramembrane proteolysis. J. Biol. Chem. 281 (2006) 14547-14553
118. Hiesberger T., Gourley E., Erickson A., Koulen P., Ward C.J., Masyuk T.V., Larusso N.F., Harris P.C., and Igarashi P. Proteolytic cleavage and nuclear translocation of fibrocystin is regulated by intracellular Ca2+ and activation of protein kinase C. J. Biol. Chem. 281 (2006) 34357-34364
119. Galichet A., Weibel M., and Heizmann C.W. Calcium-regulated intramembrane proteolysis of the RAGE receptor. Biochem. Biophys. Res. Commun. 370 (2008) 1-5
120. Carey B.W., Kim D.Y., and Kovacs D.M. Presenilin/γ-secretase and α-secretase-like peptidases cleave human MHC Class I proteins. Biochem. J. 401 (2007) 121-127
121. Martin L., Fluhrer R., Reiss K., Kremmer E., Saftig P., and Haass C. Regulated intramembrane proteolysis of Bri2 (Itm2b) by ADAM10 and SPPL2a/SPPL2b. J. Biol. Chem. 283 (2008) 1644-1652
122. Kim D.Y., Ingano L.A., and Kovacs D.M. Nectin-1 α, an immunoglobulin-like receptor involved in the formation of synapses, is a substrate for presenilin/γ-secretase-like cleavage. J. Biol. Chem. 277 (2002) 49976-49981
123. Goldschneider D., Rama N., Guix C., and Mehlen P. The neogenin intracellular domain regulates gene transcription via nuclear translocation. Mol. Cell. Biol. 28 (2008) 4068-4079
124. Gowrishankar K., Zeidler M.G., and Vincenz C. Release of a membrane-bound death domain by γ-secretase processing of the p75NTR homolog NRADD. J. Cell Sci. 117 (2004) 4099-4111
125. Wang R., Tang P., Wang P., Boissy R.E., and Zheng H. Regulation of tyrosinase trafficking and processing by presenilins: partial loss of function by familial Alzheimer's disease mutation. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 353-358
126. Nakahara S., et al. A secreted type of β 1,6 N-acetylglucosaminyltransferase V (GnT-V), a novel angiogenesis inducer, is regulated by γ-secretase. FASEB J. 20 (2006) 2451-2459
127. Kim J., Jahng W.J., Di Vizio D., Lee J.S., Jhaveri R., Rubin M.A., Shisheva A., and Freeman M.R. The phosphoinositide kinase PIKfyve mediates epidermal growth factor receptor trafficking to the nucleus. Cancer Res. 67 (2007) 9229-9237
128. Boerner J.L., Demory M.L., Silva C., and Parsons S.J. Phosphorylation of Y845 on the epidermal growth factor receptor mediates binding to the mitochondrial protein cytochrome c oxidase subunit II. Mol. Cell. Biol. 24 (2004) 7059-7071
129. de la Iglesia N., Konopka G., Puram S.V., Chan J.A., Bachoo R.M., You M.J., Levy D.E., Depinho R.A., and Bonni A. Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway. Genes Dev. 22 (2008) 449-462
130. Giri D.K., Ali-Seyed M., Li L.Y., Lee D.F., Ling P., Bartholomeusz G., Wang S.C., and Hung M.C. Endosomal transport of ErbB-2: mechanism for nuclear entry of the cell surface receptor. Mol. Cell. Biol. 25 (2005) 11005-11018
131. Wang S.C., et al. Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2. Cancer Cell 6 (2004) 251-261
132. Offterdinger M., Schofer C., Weipoltshammer K., and Grunt T.W. c-erbB-3: a nuclear protein in mammary epithelial cells. J. Cell Biol. 157 (2002) 929-939
133. Bryant D.M., and Stow J.L. Nuclear translocation of cell-surface receptors: lessons from fibroblast growth factor. Traffic 6 (2005) 947-954
134. Larkin III J., Johnson H.M., and Subramaniam P.S. Differential nuclear localization of the IFNGR-1 and IFNGR-2 subunits of the IFN-γ receptor complex following activation by IFN-γ. J. Interferon. Cytokine Res. 20 (2000) 565-576
135. Subramaniam P.S., Flowers L.O., Haider S.M., and Johnson H.M. Signal transduction mechanism of a peptide mimetic of interferon-γ. Biochemistry 43 (2004) 5445-5454
136. Subramaniam P.S., and Johnson H.M. Lipid microdomains are required sites for the selective endocytosis and nuclear translocation of IFN-γ, its receptor chain IFN-γ receptor-1, and the phosphorylation and nuclear translocation of STAT1 α. J. Immunol. 169 (2002) 1959-1969
137. Subramaniam P.S., and Johnson H.M. The IFNAR1 subunit of the type I IFN receptor complex contains a functional nuclear localization sequence. FEBS Lett. 578 (2004) 207-210
138. Bonacchi A., et al. Nuclear localization of TRK-A in liver cells. Histol. Histopathol. 23 (2008) 327-340
139. Moughal N.A., Waters C., Sambi B., Pyne S., and Pyne N.J. Nerve growth factor signaling involves interaction between the Trk A receptor and lysophosphatidate receptor 1 systems: nuclear translocation of the lysophosphatidate receptor 1 and Trk A receptors in pheochromocytoma 12 cells. Cell Signal. 16 (2004) 127-136
140. Zwaagstra J.C., Guimond A., and O'Connor-McCourt M.D. Predominant intracellular localization of the type I transforming growth factor-β receptor and increased nuclear accumulation after growth arrest. Exp. Cell Res. 258 (2000) 121-134
141. Conway-Campbell B.L., et al. Nuclear targeting of the growth hormone receptor results in dysregulation of cell proliferation and tumorigenesis. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 13331-13336
142. Lobie P.E., Mertani H., Morel G., Morales-Bustos O., Norstedt G., and Waters M.J. Receptor-mediated nuclear translocation of growth hormone. J. Biol. Chem. 269 (1994) 21330-21339
143. Lobie P.E., Wood T.J., Chen C.M., Waters M.J., and Norstedt G. Nuclear translocation and anchorage of the growth hormone receptor. J. Biol. Chem. 269 (1994) 31735-31746
144. Pereno R., et al. IL-15/IL-15Rα intracellular trafficking in human melanoma cells and signal transduction through the IL-15Rα. Oncogene 19 (2000) 5153-5162
145. Feng Y., Venema V.J., Venema R.C., Tsai N., and Caldwell R.B. VEGF induces nuclear translocation of Flk-1/KDR, endothelial nitric oxide synthase, and caveolin-1 in vascular endothelial cells. Biochem. Biophys. Res. Commun. 256 (1999) 192-197
146. Ilan N., Tucker A., and Madri J.A. Vascular endothelial growth factor expression, β-catenin tyrosine phosphorylation, and endothelial proliferative behavior: a pathway for transformation?. Lab. Invest. 83 (2003) 1105-1115
147. Lee T.H., Seng S., Sekine M., Hinton C., Fu Y., Avraham H.K., and Avraham S. Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1. PLoS Med. 4 (2007) e186
148. Gomes D.A., Rodrigues M.A., Leite M.F., Gomez M.V., Varnai P., Balla T., Bennett A.M., and Nathanson M.H. c-Met must translocate to the nucleus to initiate calcium signals. J. Biol. Chem. 283 (2008) 4344-4351
149. Garcia R.A.G., Vasudevan K., and Buonanno A. The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 3596-3601
150. Huang Y.Z., Won S., Ali D.W., Wang Q., Tanowitz M., Du Q.S., Pelkey K.A., Yang D.J., Xiong W.C., Salter M.W., and Mei L. Regulation of neuregulin signaling by PSD-95 interacting with ErbB-4 at synapses. Neuron 26 (2002) 443-455
151. Xu X., Ye S., Gambetti P., Sui D., and Cui M.Z. Identification of a novel PSD-95/Dlg/ZO-1 (PDZ)-like protein interacting with the C-terminus of presenilin-1. J. Biol. Chem. 274 (1999) 32543-32546
152. Lau K.F., McLoughlin D.M., Standen C., and Miller C.C. X11 alpha and x11 beta interact with presenilin-1 via their PDZ domains. Mol. Cell Neurosci. 16 (2000) 557-565
153. Sandvig K., and van Deurs B. Transport of protein toxins into cells: pathways used by ricin, cholera toxin and Shiga toxin. FEBS Lett. 529 (2002) 49-53
154. Bonifacino J.S., and Rojas R. Retrograde transport from endosomes to the trans-Golgi network. Nat. Rev. Cell Mol. Biol. 7 (2006) 563-579
155. Marsh M., and Helenius A. Virus entry: open season. Cell 124 (2006) 729-740